Zobrazeno 1 - 7
of 7
pro vyhledávání: '"B. G. Hohn"'
Autor:
Michael A. McGuckin, Peter L. Devine, Michael Walsh, Rachel J. Quin, Hemamali Samaratunga, A. Clague, B. G. Hohn
Publikováno v:
ResearcherID
Scopus-Elsevier
Scopus-Elsevier
The Prostate-Specific Antigen (PSA) and the Cancer-Associated Serum Antigen (CASA) assay for the MUC1 mucin were compared in the serum of 303 patients with malignant or benign prostatic disease. Using cutpoints of 4, 10, and 20 mu g/l, PSA was elevat
Publikováno v:
Human Pathology. 26:432-439
The epithelial mucin produced by the MUC1 gene is present in the apical cell membrane of normal breast epithelial cells and is highly expressed in many breast cancers. Several studies have provided conflicting evidence regarding the relationship betw
Autor:
Margaret C. Cummings, R G Wright, Ian C. Bennett, Michael A. McGuckin, Michael Walsh, B. G. Hohn
Publikováno v:
The American journal of surgical pathology. 26(10)
Axillary lymph node status is one of the most powerful prognostic factors for patients with breast cancer and is often critical in stratifying patients into adjuvant treatment regimens. In 203 apparently node-negative cases of breast cancer, a combin
Publikováno v:
Human pathology. 26(4)
The epithelial mucin produced by the MUC1 gene is present in the apical cell membrane of normal breast epithelial cells and is highly expressed in many breast cancers. Several studies have provided conflicting evidence regarding the relationship betw
Autor:
M. L. T. H. Samaratunga, B. G. Hohn, Michael A. McGuckin, Michael Walsh, Peter L. Devine, W. Thong, Robert A. Gardiner
Publikováno v:
British journal of urology. 73(3)
To examine the presence of a membrane-associated and secreted mucin (MUC1) and a secreted gel-forming mucin (MUC2) in normal and malignant urothelium.Sections were obtained from archival paraffin blocks from 11 patients with nonmalignant urological c
AIMS--To examine the expression of the MUC2 epithelial mucin in breast carcinoma; to relate this to patient survival. METHODS--Sections from 210 breast carcinomas were stained with the anti-MUC2 core protein monoclonal antibody, 4F1, using an immunop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::552d13147a52094f66280aa2a0156539
https://europepmc.org/articles/PMC501619/
https://europepmc.org/articles/PMC501619/
Publikováno v:
Pathology. 26:A2